Out For Tender › Estados Unidos › Serviços de investigação e desenvolvimento e serviços de consultoria conexos
Request of Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
- Entidade adjudicante
- BARDA - ASPR / DAAPPO / BARDA DCMA, Health and Human Services, Department of
- País
- Estados Unidos
- Categoria
- Serviços de investigação e desenvolvimento e serviços de consultoria conexos
- Prazo
- Termina a 30 Oct 2026 (30 Oct 2026 17:00 UTC-4)
- Publicado
- 17 Aug 2026
- Procedimento
- Solicitation - No Set aside used
Ler o anúncio oficial e concorrer → As propostas são sempre apresentadas no portal da entidade adjudicante, nunca aqui.
O que a entidade adjudicante procura
BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods. Mandatory Qualification Requirements: To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by: 1. Holding a U.S. influenza vaccine license; or 2. Have developed an influenza vaccine as evidenced by: a. Submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine Please see full solicitation details and proposal submission instructions detailed in attachments 01-19 of this notice.
Idioma deste anúncio: English. O título e a descrição são apresentados tal como a entidade adjudicante os publicou.
Source: SAM · reference 75A50126R00001_RFP_NPIVS_27 · JSON